Skip to content
MarketScale
‹ Back to IndustriesSciences

How Science and Technology is Revolutionizing the Cannabis Industry

Cannabis development is highly attributed to plant breeding and targeted cultivation strategies. Crops themselves are entirely different from those in the 1970s, and we’ve learned a lot by fine-tuning our techniques. According to Anders Peterson, Cannabis Operations Specialist at InSpire Transpiration Solutions, science and technology have been game-changing for cannabis development. “We’ve been able to…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Cannabis
Share

Key takeaways

01

Cannabis development is highly attributed to plant breeding and targeted cultivation strategies.

02

Crops themselves are entirely different from those in the 1970s, and we’ve learned a lot by fine-tuning our techniques.

03

According to Anders Peterson, Cannabis Operations Specialist at InSpire Transpiration Solutions, science and technology have been game-changing for cannabis development.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

Cannabis development is highly attributed to plant breeding and targeted cultivation strategies. Crops themselves are entirely different from those in the 1970s, and we’ve learned a lot by fine-tuning our techniques.

According to Anders Peterson, Cannabis Operations Specialist at InSpire Transpiration Solutions, science and technology have been game-changing for cannabis development.

“We’ve been able to collect a significant more amount of data and learn from it, even just over the past five years,” said Peterson. “Besides that, the technology used to create a controlled environment inside in terms of lighting, fertigation, HVAC, have allowed us to also optimize plant growth and production and efficiency in these spaces.

In the same ways that farmers learn over time what crops grow best in what areas, we learn to isolate environmental factors to optimize plant growth. Starting with data collection, we better understand what the plants need.

These developments have decreased the number of days plants take to reach maturity and, in turn, increased the number of harvests a year within greenhouses. Specifically, within InSprire Transpiration Solutions, technology has increased harvest cycles from four per year to six. Similar techniques are developing in outdoor cannabis development and production.

In addition to environmental developments, we have also seen cannabis development in the plants themselves through crop steering and breeding. In the 1970s, THC levels in cannabis plants consistently registered 8-12%. Nowadays, plants are testing in the range of 35 to 40% with some cultivars. That’s a significant increase. A lot of that is down to the changes in plant breeding. However, targeted cultivation strategies also contribute to that shift.

Video TranscriptExpand ↓

Hi, my name is Anders Peterson with InSpire Transpiration Solutions. I'm an indoor cannabis cultivator for the past 12 years and a cell molecular biologist. And today, the question is how was an increased understanding of technology and science changing the cannabis industry? Well, a better understanding of science and technology has changed the cannabis industry in a number of ways. And specifically, when it comes to cultivation, it has allowed us to optimize plant performance, including yield and secondary metabolite concentration like cannabinoids and terpenes. And it's allowed us to optimize the production of the plant, primarily in an indoor setting, but also in the field. And in greenhouses. An example of this in an indoor scenario is that with data collection, a better understanding of the levers to pull for cultivation in terms of the Cardinal parameters of plant growth, we've been able to shorten cycle times and basically speed up plant growth so that we're getting additional harvests per year which is just increasing the bottom line for many of these cannabis cultivation businesses. For example, a while ago, an indoor flowering room would only get four harvest a year. Now we're shooting for getting six. So that's a significant more amount of product coming out of each space per year. All due to better understanding of science and technology. The advent of cheaper sensor technology and kind of the IOT of things has allowed us to learn a lot of these things that have, uh, you know, a lot of the parameters to optimize, because sensors have gotten so much cheaper more widely accessible. We've been able to collect a significant more amount of data and learn from it, even just over the past five years. Besides that, the technology used to create a controlled environment inside in terms of lighting, fertigation, HVAC, have allowed us to also optimize plant growth and production and efficiency in these spaces. So, really it's kind of changed the game, increasing, you know, a better understanding of technology and science. I'm looking forward to some really interesting research that's going to be coming out in the next year or so, that will even further optimize these indoor controlled environments, allowing us to reach new levels of plant performance in the cannabis crop that we've never seen before. I mean, just as a benchmark of back in the seventies, most cannabis dried flower tested in the THC percentages around eight to 12%. Nowadays, we're testing in the range of 35 to 40% with some cultivars. That's a significant increase. A lot of that is done through breeding, but also much more targeted cultivation strategy. That's allowed us to use techniques like crop steering, both in the irrigation side and in the environment that allow us to push the plant in certain predicted outcomes that are beneficial for the cultivator and for the crop. So it's really been quite amazing.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Lab automation ROI hinges on integration, not instrument sensitivity claims

Lab automation ROI hinges on integration, not instrument sensitivity claims

At ADLM 2026, Waters and LabCollector delivered a clear message for lab leaders: the limiting factor in automation is often integration, not hardware. Waters introduced the Xevo TQ Absolute XR IVD mass spectrometer and is positioning it at “5x greater sensitivity” versus in-class instruments, according to SelectScience, but that advantage only carries through if sample prep, calibration and QA, middleware rules, and LIMS result review can keep pace. In parallel, LabCollector announced an AI Co-Scientist feature set for natural-language search, knowledge retrieval, and AI-assisted content creation inside ELN and LIMS workflows, also reported by SelectScience, shifting attention from pipetting speed to retrieval, approval, permissions, and versioning in systems that sit on the documentation path. The Scientist’s overview of semi-automated versus fully automated approaches reinforces the point: labs can automate in modules, but they have to run automation as one system.

  • 01The bottleneck in automation is often the handoff, instrument to middleware to LIMS, so sensitivity and throughput gains depend on interfaces and downstream review as much as the instrument spec.
  • 02Waters’ “5x greater sensitivity” positioning and LabCollector’s AI Co-Scientist both point to integration work, sample prep, calibration and QA, middleware rules, and LIMS result review, as the gating factor for ROI.
  • 03As ELN/LIMS add conversational search and AI-assisted content creation, speed gains move from pipetting to retrieval, approval, permissions, and versioning inside systems that sit in regulated or audited workflows.

Sep 3, 2026

AeroVironment to co-design three autonomous helicopters for NASA's SkyFall Mars mission

AeroVironment to co-design three autonomous helicopters for NASA's SkyFall Mars mission

AeroVironment’s MacCready Works has been contracted to build three autonomous Mars helicopters for NASA's SkyFall mission. This development highlights the company's capabilities in aerospace-grade autonomy and avionics integration. The project shows a strong connection between aerospace and defense industries in terms of supply chain management.

  • 01AeroVironment is co-designing and co-manufacturing three autonomous helicopters for NASA's SkyFall Mars mission with JPL.
  • 02SkyFall will use a 'SkyFall maneuver' where three helicopters are released from a carrier spacecraft, separate, deploy, descend, and land under their own power, avoiding a dedicated lander or host rover.
  • 03AeroVironment leads rotor systems, airframes, structures, avionics integration, and payload provisions, while JPL leads the power system, electronics, algorithms, and software.

Aug 29, 2026

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Pharmaceutical companies are increasingly using telehealth digital waiting rooms as prime advertising slots. These virtual spaces offer unique opportunities for pharma brands to engage patients before and after their virtual care visits. The trend is driven by fresh data on patient attention and strategic execution by agencies.

  • 01Pharmaceutical brands are using digital waiting rooms in telehealth platforms as premium ad slots.
  • 02New patient-attention data enhances pharma media plans for virtual care settings.
  • 03Virtual waiting rooms allow targeted patient engagement before and after healthcare consultations.

Aug 29, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512